GSE119571
Transcriptional Response of Mycobacterium tuberculosis H37Rv to clarithromycin
To understand the response of M. tuberculosis (MTB) to the first-line drug clarithromycin, we performed transcriptomics on MTB bacilli exposed to the drug. Overall design: Bacteria were harvested at 0,1 day after being exposed to concentrations of clarithromycin (no drug, 20µM) as indicated in each sample title. RNA was isolated and gene expression quantified by sequencing.